Immunome presents additional clinical data for varegacestat in desmoid tumors at ESMO 2026

Immunome, Inc. presented additional clinical data for varegacestat, its investigational oral once-daily gamma secretase inhibitor, in desmoid tumors at the 2026 ESMO Congress, showcasing new clinical analyses supporting the drug's profile.

Detected & updated continuously · Source: Nebula